FDA Opens Tobacco Rulemaking Dockets, Approves First Cannabis-Derived Drug and Reacts to the Legalization of Hemp, and Announces Plans to Significantly Change Medical Device Program

FDA Opens Tobacco Rulemaking Dockets, Approves First Cannabis-Derived Drug and Reacts to the Legalization of Hemp, and Announces Plans to Significantly Change Medical Device Program
FDLI’s Top Food and Drug Cases, 2018 & Cases to Watch, 2019
Jonathan Havens
Food and Drug Law Institute

As part of the Food and Drug Law Institute’s (FDLI) top food and drug cases and cases to watch, Jonathan Havens authored this article discussing recent Food and Drug Administration (FDA) regulatory policy updates. Jonathan, chair and co-chair of the Firm’s Food and Beverage and Cannabis Law Practices, covers the FDA’s issuance of an advance notice of proposed rulemaking for tobacco, the legalization of the first cannabis-derived drug, hemp legalization and more.